"Vanda and AnaptysBio link for generalised pustular psoriasis therapy" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has ...

The following is a summary of “Global Delphi consensus on treatment goals for generalised pustular psoriasis,” published in the January 2025 issue of Dermatology by Barker et al. Generalized pustular ...

Vanda Pharmaceuticals and AnaptysBio have announced an exclusive worldwide licence agreement to develop and commercialise the ...

A doctor may prescribe injectable treatments, such as methotrexate, TNF-alpha inhibitors, or interleukin inhibitors, for moderate to severe psoriasis when other treatments don’t work.

Efalizumab is also distinct in having shown efficacy in hand and foot psoriasis including a placebo-controlled trial (Fretzin, Crowley, Jones, Young, & Sobell, 2006; Leonardi, Sofen & Krell ...

Jan. 31, 2025 — In a new study, researchers have determined that a protein called NF-kB c-Rel can intensify the symptoms of psoriasis when activated by signals from the body's immune system.

In its Phase II, double-blind, multicenter, randomized dose-ranging study, 142 subjects with moderate-to-severe plaque psoriasis were randomized to placebo or 10, 23, 75 or 150 mg of ixekizumab.

White matter and other changes around the toenails and fingernails can occur with psoriasis or nail fungus. However, fungal infections are contagious, and psoriasis is not. The causes and ...

Although AGEP often presents similarly to generalized pustular psoriasis (GPP), distinguishing between these entities is crucial for appropriate management. This case underscores the importance of ...

Knowing which kind of psoriasis you have helps you and your doctor make a treatment plan. Most people have only one type at a time. Experts believe psoriasis is an autoimmune disease.